Roth Capital Starts Achillion Pharmaceuticals (ACHN) at Buy
Tweet
Share
E-mailGet Alerts ACHN Hot Sheet
Price: $0.79 --0%
Rating Summary:
11 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
11 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Roth Capital initiates coverage on Achillion Pharmaceuticals (NASDAQ: ACHN) with a Buy. PT $10.
For more ratings news on Achillion Pharmaceuticals click here and for the rating history of Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $5.10 yesterday.
For more ratings news on Achillion Pharmaceuticals click here and for the rating history of Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $5.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Starts Tenable (TENB) at Sector Perform
- Goldman Sachs Resumes Dada Nexus Ltd. (DADA) at Neutral
- Berenberg Starts Deutsche Bank ADRs (DB) at Hold, Maintains Hold on German Shares
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
